Matches in SemOpenAlex for { <https://semopenalex.org/work/W116474093> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W116474093 abstract "Despite dual antiplatelet therapy with aspirin and clopidogrel, patients with diabetes mellitus (DM) suffer from frequent recurrent ischemic events. Previous studies have shown that DM patients have a higher prevalence of aspirin resistance than non-DM patients. The aim of this analysis was to determine if DM patients have a decreased antiplatelet response to either maintenance or high loading clopidogrel administration when compared to non-DM patients. One hundred and thirty eight patients that underwent percutaneous coronary intervention (PCI) in the Clear Platelets-2 Study were included in this analysis. Patients were grouped according to clopidogrel dose use and presence of DM. Subjects were either on maintenance therapy with 75mg of clopidogrel (C75 group; n=72) or received a loading dose of 600mg of clopidogrel immediately after PCI (C600 group; n=66). All patients received 325-mg aspirin. Platelet function was measured by Light Transmission Aggregometry using ADP (5 and 20μM), TRAP (15 μM), and collagen (2μg/ml). Overall, DM patients in the C75 group had higher platelet aggregation using 5 and 20μM ADP and 2μg/ml collagen. DM patients had lower relative platelet inhibition at 24hrs with 5 μM ADP and 2μg/ml collagen in the C600 group when compared to non-DM patients (Table ). DM patients undergoing PCI exhibit higher platelet aggregation when receiving standard clopidogrel maintenance dose and lower relative platelet inhibition with high clopidogrel loading dose. Higher doses of clopidogrel or more potent P2Y12 receptor antagonists may be needed in DM patients to obtain comparable platelet inhibition to non-DM patients." @default.
- W116474093 created "2016-06-24" @default.
- W116474093 creator A5007372093 @default.
- W116474093 creator A5012918602 @default.
- W116474093 creator A5013356125 @default.
- W116474093 creator A5023109430 @default.
- W116474093 creator A5033408468 @default.
- W116474093 creator A5039130551 @default.
- W116474093 creator A5054496060 @default.
- W116474093 creator A5056047149 @default.
- W116474093 creator A5079308082 @default.
- W116474093 date "2008-10-28" @default.
- W116474093 modified "2023-09-26" @default.
- W116474093 title "Abstract 4017: Reduced Anti-Platelet Response to Clopidogrel in Diabetic Patients Undergoing Percutaneous Coronary Intervention" @default.
- W116474093 doi "https://doi.org/10.1161/circ.118.suppl_18.s_819-b" @default.
- W116474093 hasPublicationYear "2008" @default.
- W116474093 type Work @default.
- W116474093 sameAs 116474093 @default.
- W116474093 citedByCount "1" @default.
- W116474093 crossrefType "journal-article" @default.
- W116474093 hasAuthorship W116474093A5007372093 @default.
- W116474093 hasAuthorship W116474093A5012918602 @default.
- W116474093 hasAuthorship W116474093A5013356125 @default.
- W116474093 hasAuthorship W116474093A5023109430 @default.
- W116474093 hasAuthorship W116474093A5033408468 @default.
- W116474093 hasAuthorship W116474093A5039130551 @default.
- W116474093 hasAuthorship W116474093A5054496060 @default.
- W116474093 hasAuthorship W116474093A5056047149 @default.
- W116474093 hasAuthorship W116474093A5079308082 @default.
- W116474093 hasConcept C126322002 @default.
- W116474093 hasConcept C134018914 @default.
- W116474093 hasConcept C164705383 @default.
- W116474093 hasConcept C2777628954 @default.
- W116474093 hasConcept C2777849778 @default.
- W116474093 hasConcept C2780400711 @default.
- W116474093 hasConcept C27924281 @default.
- W116474093 hasConcept C35294091 @default.
- W116474093 hasConcept C42219234 @default.
- W116474093 hasConcept C45393284 @default.
- W116474093 hasConcept C49059817 @default.
- W116474093 hasConcept C500558357 @default.
- W116474093 hasConcept C555293320 @default.
- W116474093 hasConcept C71924100 @default.
- W116474093 hasConcept C89560881 @default.
- W116474093 hasConcept C98274493 @default.
- W116474093 hasConceptScore W116474093C126322002 @default.
- W116474093 hasConceptScore W116474093C134018914 @default.
- W116474093 hasConceptScore W116474093C164705383 @default.
- W116474093 hasConceptScore W116474093C2777628954 @default.
- W116474093 hasConceptScore W116474093C2777849778 @default.
- W116474093 hasConceptScore W116474093C2780400711 @default.
- W116474093 hasConceptScore W116474093C27924281 @default.
- W116474093 hasConceptScore W116474093C35294091 @default.
- W116474093 hasConceptScore W116474093C42219234 @default.
- W116474093 hasConceptScore W116474093C45393284 @default.
- W116474093 hasConceptScore W116474093C49059817 @default.
- W116474093 hasConceptScore W116474093C500558357 @default.
- W116474093 hasConceptScore W116474093C555293320 @default.
- W116474093 hasConceptScore W116474093C71924100 @default.
- W116474093 hasConceptScore W116474093C89560881 @default.
- W116474093 hasConceptScore W116474093C98274493 @default.
- W116474093 hasIssue "suppl_18" @default.
- W116474093 hasLocation W1164740931 @default.
- W116474093 hasOpenAccess W116474093 @default.
- W116474093 hasPrimaryLocation W1164740931 @default.
- W116474093 hasVolume "118" @default.
- W116474093 isParatext "false" @default.
- W116474093 isRetracted "false" @default.
- W116474093 magId "116474093" @default.
- W116474093 workType "article" @default.